AstraZeneca’s Tezspire meets goals in late-stage esophagitis trial
AstraZeneca says its Tezspire meets all goals in a late-stage esophagitis trial.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.